$ |
product A least expensive |
$$ |
product B more expensive than A |
$$$ |
product C more expensive than B |
$$$$ |
product D more expensive than C |
$$$$$ |
product E more expensive than D |
!!!!! |
product F is substantially more expensive than A-E |
Non-Formulary |
product G not part of the formulary |
MAC |
Maximum Allowable Cost - the maximum charge that will be paid for the product whether generic or brand. |
Drug Name (Generic Name) |
The BRAND NAME of the drug followed by generic in parentheses or the generic name only. |
Drug and/or Generic Comments |
Comments such as: (suspension only), (caps, tabs only), (tablets non-form), etc. |
Strength and/or Dosage |
The dosage of a drug covered if not all strengths are formulary as in half-strength program. |
Strength and/or Dosage Comments |
Comments related to dosage/quantity limitations. |
|
|
|
|
|
| Prev. Page | Prev. Class | Next Class | Next Page |
VASODILATOR ANTIHYPERTENSIVES
Relative Cost |
MAC |
Drug Name (Generic Name) Drug and/or Generic Comments |
Strength and/or Dosage Strength and/or Dosage Comments |
$$ |
|
CARDURA (doxazosin) |
|
$$ |
|
doxazosin mesylate (doxazosin) |
|
$$ |
|
hydralazine hcl (hydralazine) |
|
$$ |
|
HYTRIN (terazosin) |
|
$$ |
|
MINIPRESS (prazosin) |
|
$$ |
|
minoxidil (minoxidil) |
|
$$ |
|
prazosin hcl (prazosin) |
|
$$ |
|
terazosin hcl (terazosin) |
|
Non-Formulary |
|
CARDURA XL |
|
Formulary Date: 10/07/2008 Update Date: 10/09/2008 V1.3.0